Perrigo To Conduct Conference Call On May 31, 2017 At 8:30 AM ET
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
May 31, 2017 5:12 AM EDTGoldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.
Analyst Jami Rubin writes to clients in a late Tuesday note that RX prices have eroded 11-13 percent compared with company guidance of 9-11 percent for FY 2017.
"...we calculate... More
